jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
Indian Journal of Pharmaceutical Education and ResearchNOW IN
Review

Nanotechnology-Driven Approaches in Overcoming Drug Delivery Challenges for Neurodegenerative Diseases

Rajamanickam Palaniyappan1, Saravanakumar Arthanari2, Mohanraj Subramanian3, Parthiban Periyasamy4, Palanisamy Pethappachetty5, Ragupathi Ganesan3, Manivasakam Prakash6,7, Anandharaj Govindaraj1★★ Corresponding author

  1. 1Department of Pharmacy Practice, Vellalar College of Pharmacy, Thindal, Erode, Tamil Nadu, Affiliated to The Tamilnadu Dr. M.G.R. Medical.
  2. 2Department of Pharmaceutical Biotechnology, Vellalar College of Pharmacy, Maruthi Nagar, Thindal, Erode, Tamil Nadu, Affiliated to The.
  3. 3Department of Pharmacology, Vellalar College of Pharmacy, Thindal, Erode, Tamil Nadu, Affiliated to The Tamilnadu Dr. M.G.R. Medical.
  4. 4Department of Pharmaceutical Chemistry, Vellalar College of Pharmacy Thindal, Erode, Tamil Nadu, Affiliated to The Tamilnadu Dr. M.G.R.
  5. 5Department of Pharmaceutics, Vinayaka Mission’s College of Pharmacy, Vinayaka Mission’s Research Foundation (Deemed to be University).
  6. 6Department of Pharmaceutics, Vellalar College of Pharmacy, Thindal, Erode, Tamil Nadu, Affiliated to The Tamilnadu Dr. M.G.R. Medical.
  7. 7Department of Pharmaceutics, The Tamilnadu Dr. M.G.R. Medical University, Chennai, Tamil Nadu, INDIA.

CORRESPONDENCE

Anandharaj Govindaraj

Department of Pharmacy Practice, Vellalar College of Pharmacy, Thindal, Erode, Tamil Nadu, Affiliated to The Tamilnadu Dr. M.G.R. Medical.

anandpharmacist3@gmail.com

Received: 20-12-2023; Revised: 13-02-2024; Accepted: 07-10-2024.

Volume 58, Issue 4S · pp. s1185–s1200 · PUBLISHED 2024 · DOI: 10.5530/ijper.58.4s.116

View on IJPER original site ↗

ABSTRACT

The management of Neurodegenerative Diseases (NDs) is a substantial concern for healthcare systems at present. Alzheimer’s disease, frontotemporal dementia, Parkinson’s disease, prion disease, Huntington’s disease and Amyotrophic lateral sclerosis are among these conditions. Pathogenic characteristics shared by these conditions include increased oxidative stress, misfolded proteins, dysfunctional mitochondria, excitotoxicity and neuro inflammation; these ultimately result in the deterioration of the structure and function of the nervous system. Despite extensive testing, there is currently no specific medication available to halt or cure the progression of these diseases. Therapy failure in neurodegenerative illnesses is often linked to the limitations posed by P-glycoproteins, the blood-brain barrier and the blood-cerebrospinal fluid barrier. Nevertheless, recent progress in nanotechnology presents an encouraging avenue for overcoming these constraints. By leveraging nanotechnology and developing nanomaterials that facilitate the delivery of active drug candidates, there is potential to overcome these challenges. Various approaches are being explored, including drug distribution through local delivery, physicochemical disruption of the blood-brain barrier, cell-penetrating peptides, receptor-mediated transcytosis and magnetic disruption. These methods aim to surmount the obstacles associated with drug delivery. This review succinctly covers the mechanism of nanoparticles, different types of nanoparticles used in treating NDs and potential future applications of nanotechnology in clinical neuroscience. The ultimate goal is to develop innovative therapeutic strategies for effectively managing and treating neurodegenerative diseases.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Palaniyappan, R., Arthanari, S., Subramanian, M., Periyasamy, P., Pethappachetty, P., Ganesan, R., Prakash, M., & Govindaraj, A. (2024). Nanotechnology-Driven Approaches in Overcoming Drug Delivery Challenges for Neurodegenerative Diseases. Indian Journal of Pharmaceutical Education and Research, 58(4S), s1185–s1200. https://doi.org/10.5530/ijper.58.4s.116